Search

everythinglearnresearchcommunity

for

Search:↓

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Finasteride-loaded nanoparticles may help treat alopecia.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Suppressing certain hormones might help prevent prostate cancer.

New compounds may soon be tested to treat excessive hair growth in women.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.